Evoke Pharma Inc
EVOKDelisted Dec 17, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001403708
Evoke Pharma Inc was delisted on Dec 17, 2025; its insiders filed their last Form 4 on Dec 19, 2025; 15 institutions reported holding it in 13F filings for Q3 2025, worth $2.94M in total; no superinvestor held it.
Q3 2024 vs. Q2 2024
How the institutions holding Evoke Pharma Inc changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 16 | 1 | 12 | −3 |
| SharesConverted for a 1-for-12 split | 262.7K | 122 | 208.3K | −54.2K (−20.7%) |
| Value | $1.67M | $774 | $994.6K | −$672.0K (−40.3%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (4)
Institutions that held Evoke Pharma Inc at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Corsair Capital Management, L.P. | 11,667 | $55.5K | 0.01% |
| BlackRock, Inc. | 122 | $581 | 0.00% |
| Citigroup Inc | 4 | $20 | 0.00% |
| Danske Bank A/S | 2 | $10 | 0.00% |
Sold out (7)
Institutions that held Evoke Pharma Inc at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Altium Capital Management LP | 692,440 | $366.3K |
| Geode Capital Management, LLC | 49,691 | $26.3K |
| Vanguard Group Inc | 29,851 | $15.8K |
| Citadel Advisors LLC | 11,911 | $6.30K |
| State Street Corp | 10,660 | $5.64K |
| FMR LLC | 71 | $38 |
| Royal Bank of Canada | 28 | $0 |
Not filed for Q3 2024 yet (1)
Institutions that held Evoke Pharma Inc at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 1,464 | $774 |